From Bench Chemistry to Promising Biomedical Applications.
First Statement of Responsibility
Giorgia Pastorin
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Milton
Name of Publisher, Distributor, etc.
Pan Stanford Publishing
Date of Publication, Distribution, etc.
2019
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(391 pages)
GENERAL NOTES
Text of Note
7.2.3.3 Electric luminescence
CONTENTS NOTE
Text of Note
Cover; Half Title; Title Page; Copyright Page; Contents; Contributors; Preface; 1. Stabilisation of Carbon Nanotube Suspensions; 1.1 Introduction; 1.2 Functionalised CNTs for Drug Delivery; 1.3 Surface-Active Agents in Stabilising CNT Suspensions; 1.4 Stabilisation of Aqueous Suspensions of Carbon Nanotubes by Self-Assembling Block Copolymers; 1.5 Stabilisation of Aqueous Suspensions of Carbon Nanotubes by Chitosan and its Derivatives; 2. Biomedical Applications I: Delivery of Drugs; 2.1 Introduction; 2.2 Non-Covalent Functionalisation on the External Walls 2.3 "Defect" Functionalisation at the Tips and Sidewalls2.4 Covalent Functionalisation on the External Sidewalls; 2.5 Encapsulation Inside CNTs; 2.6 Conclusions and Perspectives; 3. Biomedical Applications II: Influence of Carbon Nanotubes in Cancer Therapy; 3.1 Importance of Nanotechnology in Cancer Therapy; 3.2 Carbon Nanotubes: A Brief Overview; 3.3 Carbon Nanotubes as Drug Vectors in Cancer Treatment; 3.4 Delivery of Oligonucleotides Mediated by Carbon Nanotubes; 3.5 Carbon Nanotubes in Radiotherapy; 3.6 Carbon Nanotubes in Thermal Ablation; 3.7 Biosensors Based on Carbon Nanotubes 3.8 Conclusions4. Biomedical Applications III: Delivery of Immunostimulants and Vaccines; 4.1 Introduction to the Immune System; 4.2 Immunogenic Response of Peptide Antigens Conjugated to Functionalised CNTs; 4.2.1 Fragment Condensation of Fully Protected Peptides; 4.2.2 Selective Chemical Ligation; 4.3 Interaction of Functionalised CNTs with CPG Motifs and Their Immunostimulatory Activity; 4.4 Immunogenicity of Carbon Nanotubes; 4.5 Conclusions; 5. Biomedical Applications IV: Carbon Nanotube-Nucleic Acid Complexes for Biosensors, Gene Delivery and Selective Cancer Therapy; 5.1 Introduction 5.2 Interaction of CNTs with Nucleic Acids5.3 Sensors and Nanocomposites; 5.4 CNT-Nucleic Acid Complexes for Gene Delivery and Selective Cancer Treatment; 6. Biomedical Applications V: Influence of Carbon Nanotubes in Neuronal Living Networks; 6.1 Introduction; 6.2 Effects of Carbon Nanotubes on Neuronal Cells' Adhesion, Growth, Morphology and Differentiation; 6.3 Electrical Stimulation of Neuronal Cells Grown on Carbon Nanotube-Based Substrates; 6.4 Investigation of the Mechanisms of the Electrical Interactions Between CNTs and Neurons; 6.5 Conclusions and Perspectives 7. Biomedical Applications VI: Carbon Nanotubes as Biosensing and Bio-interfacial Materials7.1 Introduction; 7.2 Biosensor; 7.2.1 Structure and Electric Properties of CNTs; 7.2.2 CNTs as Electric Sensors; 7.2.2.1 CNT-based electric devices; 7.2.2.2 CNT-based sensors; 7.2.2.2.1 Mass/force sensor; 7.2.2.2.2 Chemical sensors; 7.2.2.2.3 Structure sensor; 7.2.2.2.4 Electric probes; 7.2.2.2.5 Microscope sensors; 7.2.2.2.6 Liquid flow sensor: transfer momentum to current; 7.2.3 Fluorescence Emission, Quenching and Detection; 7.2.3.1 Fluorescence emitter; 7.2.3.2 Raman spectrum